Kfir Oved - Concepedia

Author

Kfir Oved

Technion – Israel Institute of Technology ORCID

Also Known As

K Oved, K. Oved, Kfir Oved

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Technion – Israel Institute of Technology Tirat Carmel Mental Health Center MeMed (Israel)Hillel Yaffe Medical Center Bnai Zion Medical Center

About

Kfir Oved is an author at Technion – Israel Institute of Technology specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	539
2	Cell Biology	5	5	128
3	Epidemiology	3	3	96
4	Health Sciences	2	2	61
5	Cellular Therapies	1	1	38

Kfir Oved

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections Kfir Oved, Asi Cohen, Olga Boico, PLoS ONE Viral DiagnosticsViral PathogenesisImmunologyViral Structural ProteinHost Response	2015	224
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation Kfir Oved, Liraz Olmer, Yonat Shemer‐Avni, EClinicalMedicine	2020	152
Validation of a Novel Assay to Distinguish Bacterial and Viral Infections Isaac Srugo, Adi Klein, Michal Stein, PEDIATRICS	2017	120
Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment) Chantal B. van Houten, Asi Cohen, Dan Engelhard, European Journal of Clinical Microbiology & Infectious Diseases	2019	113
A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study Liat Ashkenazi‐Hoffnung, Kfir Oved, Roy Navon, European Journal of Clinical Microbiology & Infectious Diseases	2018	88
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study Cihan Papan, Alberto Argentiero, Marian Porwoll, Clinical Microbiology and Infection	2021	85
Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19 Shaul Lev, Tamar Gottesman, Gal Sahaf Levin, PLoS ONE	2021	61
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. Gal Markel, Tali Cohen-Sinai, Michal J. Besser, PubMed Generation TechnologyCell TherapyImmunologyImmunoeditingImmunotherapy	2009	38
A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infections Michal Stein, Shelly Lipman‐Arens, Kfir Oved, Diagnostic Microbiology and Infectious Disease Host FactorViral DiagnosticsRespiratory InfectionVirologyInfectious Respiratory Disease	2017	38
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts<i>in vivo</i> Avital Lev, Roy Noy, Kfir Oved, Proceedings of the National Academy of Sciences ImmunologyAntigen ProcessingImmunotherapeuticsImmunotherapyCancer Biology	2004	37

Page 1